Artivion, Inc.
AORT
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. Itā¦ read more
Healthcare
Medical Devices
33 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$27.87
Price+3.86%
$1.04
1Y
Price
Market Cap
$1.353b
Small
Price/Earnings 3y Avg5y Avg
42.9x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+10.4%
EBITDA Margin+1.2%
Net Profit Margin-5.9%
Free Cash Flow Margin+10.4%
EBITDA Margin+1.2%
Net Profit Margin-5.9%
Free Cash Flow MarginRevenue
$458.689m
+3.9%
1y CAGR+9.1%
3y CAGR+10.0%
5y CAGREarnings
$11.690m
+19.7%
1y CAGR+83.1%
3y CAGR+47.3%
5y CAGREPS
$0.24
+14.3%
1y CAGR+79.1%
3y CAGR+45.3%
5y CAGRBook Value
$450.467m
$883.157m
Assets$432.690m
Liabilities$258.157m
DebtDebt to Assets
29.2%
4x
Debt to EBITDAFree Cash Flow
$12.831m
+1508.5%
1y CAGR+465.7%
3y CAGR+392.2%
5y CAGRNo items found.
Press Releases
Statements and updates from the company